Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis

<div>Receiver operating characteristic (ROC) curves for serum NOS2, nNO, and combined serum NOS2 and nNO distinguish responder from nonresponder in AR with SCIT. NOS2: inducible nitric oxide synthase; nNO: nasal nitric oxide; SCIT: subcutaneous immunotherapy.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis 

Figure 4 | Predictive Value of Nasal Nitric Oxide and Serum NOS2 Levels in the Efficacy of Subcutaneous Immunotherapy in Pediatric Patients with Allergic Rhinitis 